Neuroscience
Positron Emission Tomography
100%
Mild Cognitive Impairment
67%
Parkinson's Disease
67%
Positron Emission Tomography
60%
Single-Photon Emission Computed Tomography
60%
Fluorine-18
40%
In Vivo
37%
Cholinergic
35%
Dopaminergic
33%
Tractography
33%
Magnetic Resonance Imaging
29%
Neural Network
25%
Alzheimer's Disease
24%
Structural Magnetic Resonance Imaging
23%
Brain Metabolism
21%
Acetylcholine
20%
Episodic Memory
16%
Dementia with Lewy Bodies
16%
Electroencephalography
16%
Nuclear Medicine
16%
Ischemia
16%
Ictal
16%
Brain Network
16%
Functional Magnetic Resonance Imaging
16%
Multiple Sclerosis
16%
Traumatic Brain Injury
16%
Neurotrauma
16%
Neuromyelitis Optica
16%
Subthalamic Nucleus
16%
Cerebellum
14%
Amyloid
12%
Vesicular Acetylcholine Transporter
12%
Stereotypic Movement Disorder
11%
Diffusion MRI
10%
Thalamus
9%
Bradykinesia
8%
Intractable Epilepsy
8%
Acetazolamide
8%
Focal Epilepsy
8%
Artificial Neural Network
8%
Tremor
7%
Nervous System Disorder
6%
Hippocampus
6%
Anisotropy
6%
Gray Matter
5%
Medicine and Dentistry
Alzheimer's Disease
35%
Positron Emission Tomography
32%
Positron Emission Tomography
32%
Magnetic Resonance Imaging
27%
Mild Cognitive Impairment
25%
Parkinson's Disease
22%
Single-Photon Emission Computed Tomography
18%
Systematic Review
16%
Brain Perfusion
16%
Functional Magnetic Resonance Imaging
16%
Fluorodeoxyglucose
16%
Diaschisis
16%
Heart Muscle Ischemia
16%
Thalamotomy
16%
MR-guided Focused Ultrasound
16%
Sinoatrial Node
16%
Prospective Study
16%
Subthalamic Nucleus
16%
Adverse Event
13%
Disease
10%
Heart Muscle Perfusion
10%
Stereotypic Movement Disorder
10%
Unified Parkinson's Disease Rating Scale
10%
Diffusion MRI
8%
Partial Seizure
8%
Drug Resistant Epilepsy
8%
Patient with Epilepsy
8%
Epileptic Seizure
8%
Medicine
8%
Structural Magnetic Resonance Imaging
6%
Weakness
6%
Bradykinesia
6%
Dyskinesia
6%
Confusion
6%
Fluorodeoxyglucose F 18
6%
Left Hemisphere
6%
Carbon 11
6%
Amyloid
6%
Essential Tremor
5%
Contralateral
5%
Keyphrases
Subthalamotomy
16%
Alzheimer's Disease
16%
Pharmaco-resistant
16%
AD Dementia
16%
Cerebral Perfusion
16%
Dihydrotetrabenazine
16%
Dual-tracer PET
16%
Intervention Effect
16%
Brain Perfusion SPECT
16%
Lesion Filling
16%
Alzheimer's Disease Classification
16%
Focused Ultrasound
16%
Parkinson's Disease
16%
Subthalamic nucleus
16%
Network Graph Analysis
14%
Correlation Network
11%
Flow Correlation
11%
Mild Cognitive Impairment
11%
Unified Parkinson's Disease Rating Scale (UPDRS)
10%
Adverse Events
10%
Vesamicol
8%
Brain Cognitive Function
8%
Hippocampus Hippocampus
8%
Nigrostriatal Tract
7%
Machine Learning Performance
6%
Acute Confusional State
6%
Tremor
6%
Bradykinesia
6%
Dyskinesia
6%
Ablation
6%
Parkinson Patients
6%
Network Modularity
5%
Physical Activity Intervention
5%
Drug-refractory Epilepsy
5%
Ictal Electroencephalography
5%
Alzheimer's Disease Patient
5%